IL7 and cancer: To compare our results for the combined use of two cancer biomarkers (i.e., CA-125 and IL-7) with the results in [25] for the use of only one cancer biomarker (CA-125), we start in Fig. 2 by showing the time-evolution of tumour cells and the CA-125 biomarker in the absence of any immune response or immune biomarker, under the assumptions that CA-125 can be produced by (b) tumour cells alone, or (c) tumour and healthy cells.